2480 — Beijing Luzhu Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.91bn
- HK$3.74bn
Annual cashflow statement for Beijing Luzhu Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -539 | -725 | -249 | -168 | -150 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 512 | 640 | 45 | 14.2 | 3.44 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.98 | -1.82 | -1.72 | 42.9 | -13.3 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -19.2 | -77.3 | -190 | -86.1 | -129 |
| Capital Expenditures | -78.5 | -257 | -87.1 | -98.4 | -61.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -325 | 33.8 | 186 | 50.8 | -63.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -404 | -223 | 98.6 | -47.6 | -125 |
| Financing Cash Flow Items | 443 | 329 | -34 | -0.664 | -6.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 455 | 337 | 273 | 14.9 | 155 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 31.8 | 36.9 | 189 | -118 | -99.9 |